The AI Product That Nobody Buys
You built an AI product. The demo is impressive. The technology works. Early beta users say they love it. Your pitch deck is polished.
But nobody is buying.
Not because your product is bad. Not because your market does not exist. Not because your price is wrong.
Because your product is a vitamin, and the market buys painkillers.
This distinction — originally articulated by Kevin Hale at Y Combinator and formalized in the Kellogg School of Management's product strategy curriculum — is the single most important positioning decision for AI companies.
Vitamins vs. Painkillers: The Framework
Vitamins are products that are nice to have. They provide general improvement, long-term benefits, and preventive value. People acknowledge they should take their vitamins. Most people do not.
Painkillers are products that solve an immediate, painful problem. The customer is in pain right now. They need relief right now. They will pay for it right now.
| Dimension | Vitamin | Painkiller |
|---|---|---|
| Customer motivation | "Should have" | "Must have" |
| Sales cycle | Long, educational | Short, urgent |
| Budget source | Innovation/exploration | Operations/necessity |
| Decision maker | Forward-looking executive | Person experiencing the pain |
| Churn risk | High (first thing cut) | Low (too painful to remove) |
| Pricing power | Low (perceived as optional) | High (worth any reasonable price) |
The brutal truth for AI companies: Most AI products are positioned as vitamins. "AI-powered insights." "Intelligent automation." "Smart analytics." These are vitamin messages. They describe general improvement, not specific pain relief.
Why AI Products Default to Vitamin Positioning
There are three systemic reasons AI products end up as vitamins:
Reason 1: The Technology-First Trap
Most AI companies are founded by technologists who are excited about what the technology can do, not what the customer needs it to do.
The pitch goes: "Our model can process 10,000 documents per second with 95% accuracy." That is a capability statement, not a pain statement. The customer hears: "This is interesting technology. I will evaluate it when I have time."
The fix: Start with the pain, not the technology. "Your compliance team spends 200 hours per month manually reviewing contracts. We reduce that to 20 hours." Now the customer hears: "This solves my specific problem."
Reason 2: The "AI" Label Is a Vitamin Word
The word "AI" has been so overused that it has become a vitamin word. It signals "interesting but not urgent." When a customer sees "AI-powered," they mentally categorize it as "innovation project" — which means long evaluation cycles, pilot programs, and decisions that get delayed quarter after quarter.
The fix: Remove "AI" from your positioning. Seriously. Instead of "AI-powered contract review," say "automated contract review that cuts review time by 90%." The customer does not care if it is AI, ML, rule-based, or magic. They care about the outcome.
Reason 3: Selling to the Wrong Person
Vitamins are sold to executives who are thinking about the future. Painkillers are sold to operators who are suffering right now.
If you are selling your AI product to the CTO because "it uses state-of-the-art NLP," you are selling a vitamin to someone who collects vitamins. If you sell it to the head of compliance because "it eliminates the 3-week backlog that is causing regulatory risk," you are selling a painkiller to someone in pain.
The fix: Find the person who feels the pain every day and sell to them. Let them champion the purchase internally.
The Kellogg Urgency Framework
The Kellogg School's product positioning framework uses four dimensions to assess where your product falls on the vitamin-to-painkiller spectrum:
Dimension 1: Frequency of Pain
How often does the customer experience this problem?
- Daily pain = Painkiller (strong urgency)
- Weekly pain = Moderate urgency
- Monthly or quarterly pain = Vitamin territory
For AI products: A customer service team dealing with 500 tickets per day has daily pain. A finance team that does quarterly forecasting has quarterly pain. The daily pain product sells faster.
Dimension 2: Intensity of Pain
How severe is the impact when the problem occurs?
- Revenue loss or regulatory penalty = High intensity
- Inefficiency or frustration = Moderate intensity
- Minor inconvenience = Low intensity
For AI products: An AI system that prevents manufacturing defects (which cost €50,000 each) has high-intensity positioning. An AI system that "provides better insights" has low-intensity positioning.
Dimension 3: Awareness of Pain
Does the customer know they have this problem?
- Customer actively searching for solutions = Aware (great for painkillers)
- Customer knows the problem exists but is not prioritizing it = Semi-aware (vitamin risk)
- Customer does not realize they have the problem = Unaware (hardest to sell)
For AI products: If the customer is already spending money on the problem (manual processes, outsourced work, legacy software), they are aware. If you have to educate them about why they need AI, you are selling a vitamin.
Dimension 4: Willingness to Pay
Does the customer have budget for this problem?
- Existing budget line item = Strong willingness
- Requires new budget approval = Moderate willingness
- "We'll find budget somewhere" = Low willingness (vitamin signal)
For AI products: If the customer is currently paying for the manual process your AI replaces, the budget exists. If your AI product requires new budget from the "innovation" fund, you are a vitamin.
Scoring Your Product
Rate each dimension 1-5. Multiply all four scores.
- Score 400-625: Strong painkiller. Sales should be relatively straightforward.
- Score 100-399: Moderate urgency. You need strong ROI evidence and customer proof points.
- Score 1-99: Vitamin. You have a positioning problem to solve before scaling sales.
Converting Your AI Vitamin Into a Painkiller
If your product scores as a vitamin, you have three options:
Option 1: Reposition the Same Product
You do not need to change the product. You need to change the story.
Before (vitamin): "Our AI platform provides intelligent document analysis for enterprise teams."
After (painkiller): "Your legal team spends 40% of their time reading contracts. We give them that time back — with 95% accuracy and zero training required."
Same product. Completely different urgency level.
The repositioning formula:
- Name the specific pain ("Your legal team spends 40% of their time reading contracts")
- Quantify the cost of the pain ("That is €300,000/year in lawyer time on tasks a machine can do")
- State the relief ("We give them that time back")
- Remove the objection ("95% accuracy, zero training required")
Option 2: Find a Different Customer
Sometimes the product is a vitamin for one buyer and a painkiller for another.
Example: An AI meeting summarization tool is a vitamin for a VP who has an assistant to take notes. But it is a painkiller for a solo founder who attends 8 meetings a day and cannot remember what was decided in any of them.
Same product. Different customer. Different urgency.
Option 3: Add a Painkiller Feature
Sometimes you need to add a specific capability that transforms the product from nice-to-have to must-have.
Example: An AI analytics dashboard is a vitamin (everyone has dashboards). But add automated anomaly detection with real-time alerts — "We will tell you when something is going wrong before it costs you money" — and now you have a painkiller.
The painkiller feature is usually not the most technically impressive feature. It is the feature that solves the most acute pain.
The Messaging Test
Here is a quick test for your current messaging. Show your website headline or pitch to someone who knows nothing about your company. Ask them:
- "What problem does this solve?"
- "How urgent is that problem?"
- "Would you pay for this today or put it on a list for later?"
If the answer to question 3 is "put it on a list," you have a vitamin. Rewrite until the answer is "today."
Case Study: From Vitamin to Painkiller
A client came to us with an "AI-powered data quality platform." Their messaging: "Ensure data quality across your enterprise with intelligent monitoring and automated remediation."
Diagnosis: Pure vitamin. General benefit, no specific pain, no urgency.
We worked with them to identify the sharpest pain their product solved:
New messaging: "Bad data costs the average enterprise €12.9 million per year (Gartner). Our platform catches data quality issues before they hit your analytics, your ML models, and your customers. Companies using our platform reduced data-related incidents by 73% in the first quarter."
Result: Sales cycle shortened from 9 months to 3 months. Win rate doubled. Same product.
How Hyperion Consulting Helps AI Companies With Product Positioning
At Hyperion Consulting, we specialize in helping AI companies transform their positioning from vitamin to painkiller. Our AI Product Strategy services include customer pain analysis, competitive positioning, messaging development, and go-to-market planning.
We do not help you build better AI. We help you sell the AI you have built.
Is your AI product a vitamin or a painkiller? Book a free consultation to find out — and fix it.
